Speaker illustration

Doctor Ole-Christian Walter Rutherford

Sykehuset Ostfold Kalnes, Sarpsborg (Norway)

Comparison of warfarin, dabigatran, rivaroxaban and apixaban for effectiveness and safety among elderly patients with atrial fibrillation: a nationwide cohort study

Event: ESC Congress 2020

Topic: Oral Anticoagulation

Session: Oral Anticoagulant Therapy in the Elderly with Atrial Fibrillation


Effectiveness and safety of apixaban, dabigatran and warfarin compared to rivaroxaban in non-valvular atrial fibrillation; a Norwegian nationwide cohort study

Event: ESC Congress 2019

Topic: Treatment

Session: Prevention of thromboembolism and atrial remodelling in atrial fibrillation


A new score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs

Event: ESC Congress 2018

Topic: Oral Anticoagulation

Session: Atrial fibrillation - Stroke prevention 2


ESC 365 is supported by

logo Novo Nordisk